<!DOCTYPE html>
<html lang="en">
<head>
    <title>MEBO RESEARCH</title>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/css/bootstrap.min.css">
    <link href="https://fonts.googleapis.com/css?family=Abel" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:400,500,700" rel="stylesheet">
    <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.2.0/css/all.css"
          integrity="xxx" crossorigin="anonymous">
    <link href="css/montserrat.css" rel="stylesheet" type="text/css">
    <link href="css/lato.css" rel="stylesheet" type="text/css">
    <link href="css/main.css" rel="stylesheet" type="text/css">
    <link rel="stylesheet" href="css/timeline.css" type="text/css">
	
	<link rel="shortcut icon" href="./images/favicon.ico" type="image/x-icon">
    <link rel="icon" href="./images/favicon.ico" type="image/x-icon">


	<script src='https://kit.fontawesome.com/a076d05399.js'></script>
</head>
<body id="mainPage" data-spy="scroll" data-target=".navbar" data-offset="60">

<nav class="navbar navbar-default navbar-fixed-top">
    <div class="container">
        <div class="navbar-header">
            <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                <span class="icon-bar"></span>
                <span class="icon-bar"></span>
                <span class="icon-bar"></span>
            </button>
            <a class="navbar-brand" href="#mainPage">		        <img src="./images/mebo-wplogo3.jpg" width="140" height="65" alt="MEBO Logo"></a>
	
					
        </div>
        <div class="collapse navbar-collapse" id="myNavbar">
            <ul class="nav navbar-nav navbar-right">
                <li><a href="#intro">Studies</a></li>
	                <li><a href="https://www.meboblog.com/">Blog</a></li>
			
                <li><a href="#donations">Donate</a></li>
                 <li><a href="#mission">Mission</a></li>
                <li><a href="#program">Events</a></li>
                <li><a href="#contact">Contact</a></li>
            </ul>
        </div>
    </div>
</nav>
<div class="jumbotron text-center">
    <h1>MEBO Research, Inc.</h1>
    <h3>Patient Advocacy
	</h3>
    <i>MEBO Research, Inc. is a sufferer-founded patient advocacy international campaign registered in the 
	State of Florida, U.S., since April 21, 2010, under section 501(c)(3) of the Internal Revenue Code, 
	classification of Public Charity. MEBO Research is also registered in England and Wales as a 
	Not For Profit, Limited by Guarantee Company (2009) and is being registered in Kenya as MEBO Africa (2021). <br>
	MEBO’s Mission is to initiate research into rare genetic metabolic diseases, particularly those resulting in systemic, difficult to control body malodor and halitosis, 
	including but not limited to Trimethylaminuria. 
	MEBO’s main strategies are to encourage self help, engage professional help, raise awareness in the public and medical community and 
	contribute to diagnostic and therapeutic advances. 
	</i>
</div>
MEBO is a 
	<a href="https://rarediseases.org/organizations/mebo-research-inc/">NORD</a>
	and <a href="https://rarediseases.org/organizations/mebo-research-inc/">EURORDIS</a> Organization Member and its directors are moderators of the 
	Trimethylaminuria 
	Community 
	at <a href="https://rareconnect.org/">RareConnect.org</a>. MEBO is referenced as an Advocacy and Support Organization in websites 
	like the 
	<a href="https://www.diseaseinfosearch.org/Trimethylaminuria/7223">Genetic Alliance</a> and 
	<a href="http://www.orpha.net/consor/cgi-bin/SupportGroup_Search.php?lng=EN&data_id=94333&title=MEBO-Research--England-and-Wales-">
	Orphanet</a>.  
	
	Additionally, MEBO focuses on bringing together the world-wide community, 
	through local and online support groups with peer-to-peer focused communications. 
	The MEBO Research website, blogs, and online support groups in English, Spanish, and Portuguese provide 
	a great deal of support and information into these rare diseases to many sufferers around the world.   
<div id="intro" class="container-fluid row">
    <div class="row" style="width: 66%; margin-left: auto; margin-right: auto;">
        <div class="col-sm-8">
            <h2>Clinical trials</h2>
				

             
   
				

 					                        <small>approved by MeBO Research IRB</small> 

                <div class="containertime timeleft" style="margin-top: 0;">
                    <div class="timecontent">
                         <p>
						 
					
   <li><a href="https://clinicaltrials.gov/ct2/show/NCT04832932">NCT04832932</a>	  &nbsp;
  - The COVID-19 Back-to-Normal Study - 
    <a href="https://www.aurametrix.com/nct04832932.html">Docs - </a>&nbsp; 2021-
  
   <li><a href="https://clinicaltrials.gov/ct2/show/NCT03451994">NCT03451994</a>	  &nbsp;
  - Exploratory Study of VOCs in Breath - 
   <a href="https://aurametrix.com/nct0345199.html">Docs - </a>&nbsp;2013-2021
   

  <li><a href="https://clinicaltrials.gov/ct2/show/NCT03582826">NCT03582826</a>  &nbsp;
  - Microbial Basis of MEBO and PATM - 
     <a href="https://aurametrix.com/Studies/mebo-patm-docs">Docs - </a>&nbsp;2018-2020&nbsp;
  

  
  
   <li><a href="https://clinicaltrials.gov/ct2/show/NCT02692495.html">NCT02692495</a>  &nbsp;
   - Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis - 
   <a href="https://www.aurametrix.com/nct02692495.html">Docs - </a>&nbsp;2009-2012&nbsp;
   
   
   <li><a href="https://clinicaltrials.gov/ct2/show/NCT02683876">NCT02683876</a>  &nbsp;
      - Exploratory Urine Metabolomics	-			 
	 <a href="https://aurametrix.com/NCT2683876.html">Docs - </a>&nbsp;2015-2018&nbsp;	 

						 
						 </p>
                    </div>
                </div>
                <div class="containertime timeright">
                    
                </div>
                
                <div class="session-break">
                    <div class="session-title">
                        <i class="fa fa-diagnoses" style="font-size:36px;color:red"></i>
                    </div>
                </div>
                <div class="session-break">
                    <div class="session-title">
                         <a href="	https://clinicaltrials.gov/ct2/results?cond=&term=mebo+research&cntry=&state=&city=&dist=	 
			">
						 				...</a>
                    </div>
                </div>
                <div class="containertime timeleft" style="margin-top: 0;">
  
                </div>  
<br>

	

									

                 </div>  
<br>
				

        </div>
 
    </div>
</div>

<div id="donations" class="container-fluid bg-grey">
    <div class="row">
    <ul class="tabs">
        <div class="col-sm-2"></div>
        <div class="col-sm-8">
            <h2></h2>
			
 


</ul>


        
        </div>


	
        <div class="col-sm-2"></div>
    </div>
</div>


<div id="YV" class="container-fluid bg-grey">
    <div class="row">
        <div class="col-sm-2"></div>
        <div class="col-sm-8">
            <h2>Donate</h2>
 <table>
    <tr>
      <td colspan="2">
      <div><strong>
        DONATIONS<br>
        <br>
        MeBO Research USA</strong><br>
        Registered Charity<br>
        Click the Donate button to make a <br>
        tax-deductable donation here:<br>
        <br>
        <form action="https://www.paypal.com/cgi-bin/webscr" method="post">
          <input src="https://www.paypal.com/en_US/i/btn/btn_donateCC_LG.gif" name="submit" alt="PayPal - The safer, easier way to pay online!" type="image" border="0">
          <img alt="" src="https://www.paypal.com/en_US/i/scr/pixel.gif" width="1" border="0" height="1">
        </form>
        or paypal direct to :<br>
        <a href="mailto:tax-deductible-donations@meboresearch.org/">tax-deductible-donations@meboresearch.org</a><br>
        <br>
      </div>
        <div><strong>MeBO Research UK</strong><br>
          Only for donations made from outside USA.<br>
          Not tax deductible.<br>
          Supports the UK Company only.<br>
          <br>
          <form action="https://www.paypal.com/cgi-bin/webscr" method="post">
            <input type="image" src="https://www.paypal.com/en_US/GB/i/btn/btn_donateCC_LG.gif" border="0" name="submit2" alt="PayPal - The safer, easier way to pay online.">
            <img alt="" border="0" src="https://www.paypal.com/en_GB/i/scr/pixel.gif" width="1" height="1">
          </form>
          or paypal direct to:  <br>
      <a title="" href="mailto:donations@meboresearch.org/">donations@meboresearch.org</a></div></td>
    </tr>
    <tr>
 </table>
        </div>
        <div class="col-sm-2"></div>
    </div>
</div>


<div id="mission" class="container-fluid">
    <div class="row">
        <div class="col-sm-2"></div>
        <div class="col-sm-8">
       <strong>MEBO Research, Inc.</strong>, (MEBO) is a sufferer-founded patient advocacy international campaign registered in the State of Florida, U.S., since April 21, 2010, under section 501(c)(3) of the Internal Revenue Code, classification of Public Charity. 
	   MEBO Research is also registered in England and Wales as a Not For Profit, Limited by Guarantee Company (2009).
       MEBO Africa was registered in 2021. 

	   MEBO is a 
	   <a href="https://rarediseases.org/organizations/mebo-research-inc/" target="_blank" data-saferedirecturl="https://www.google.com/url?hl=en&q=https://rarediseases.org/organizations/mebo-research-inc">NORD</a> and <a href="https://www.eurordis.org/sites/default/files/members.pdf" target="_blank" data-saferedirecturl="https://www.eurordis.org/sites/default/files/members.pdf">EURORDIS</a> Organization Member and its directors are moderators of the 
	   Trimethylaminuria Community at <a href="https://rareconnect.org/" target="_blank">RareConnect.org</a>. 
	   MEBO is referenced as an Advocacy and Support Organization in websites like the 
	   <a href="https://www.diseaseinfosearch.org/Trimethylaminuria/7223" target="_blank">
	   Genetic Alliance</a> and <a href="http://www.orpha.net/consor/cgi-bin/SupportGroup_Search.php?lng=EN&data_id=94333&title=MEBO-Research--England-and-Wales-" target="_blank" data-saferedirecturl="https://www.google.com/url?hl=en&q=https://www.orpha.net/consor/cgi-bin/SupportGroup_Search.php?lng%3DEN%26data_id%3D94333%26title%3DMEBO-Research--England-and-Wales-&source=gmail&ust=1490148160573000&usg=AFQjCNHx-E9W16IlQfd6FWTOHSXnDCoGNg">Orphanet</a>. 
	   
<!--	   MEBO is the impacted group for the <a href="http://gtr.rcuk.ac.uk/project/772B5BB8-C185-455B-9AE2-C4BC7F8369DF" target="_blank" data-saferedirecturl="https://www.google.com/url?hl=en&q=https://gtr.rcuk.ac.uk/project/772B5BB8-C185-455B-9AE2-C4BC7F8369DF&source=gmail&ust=1490148160573000&usg=AFQjCNHkxhmYoebokZN3hwGZjI4mrgiDTg">MRC Research Grant of</a><a href="http://gtr.rcuk.ac.uk/project/772B5BB8-C185-455B-9AE2-C4BC7F8369DF" target="_blank" data-saferedirecturl="https://www.google.com/url?hl=en&q=https://gtr.rcuk.ac.uk/project/772B5BB8-C185-455B-9AE2-C4BC7F8369DF&source=gmail&ust=1490148160573000&usg=AFQjCNHkxhmYoebokZN3hwGZjI4mrgiDTg"> £360,684</a>, as noted in the 'Outcomes' Tab of the Gateway to Research, Research Councils UK site.  </p>
    -->
	
	   <p><strong>MEBO&rsquo;s Mission</strong> is to initiate research into rare genetic metabolic diseases, particularly those resulting in systemic, difficult to control body malodor and halitosis, including, but not limited to, Trimethylaminuria. Studies such as the &quot;<strong><a href="#currentstudy">Dynamics of the Gut Microbiota in Idiopathic Malodor Production</a></strong>&quot; and &quot;MEBO Metabolic Profiling&quot; are ground-breaking studies which explore innovative insight into conditions of malodor and/or PATM. The study <a href="https://clinicaltrials.gov/ct2/show/study/NCT02683876?term=NCT02683876&rank=1" target="_blank"> &quot;Exploratory Study of Relationships Between Malodor and Urine Metabolomics&quot; (ClinicalTrials.gov Identifier: NCT02683876)</a> was created to identifying metabolic signatures associated with malodor conditions. In addition, MEBO pursues studies of analysis and categorization of gut microbiota -to characterize the genes that the microbes are expressing -in an effort to identify and understand microbial communities that could produce malodor symptoms. The aim is to identify effective targeted course of treatment to control symptoms, and preferably cure the conditions as a result of these and other research efforts. <br>
          <br>
          Additionally, MEBO focuses on bringing together the world-wide community, through local and online support groups with peer-to-peer focused communications. The MEBO Research website, blogs, and online support groups in English, Spanish, and Portuguese provide a great deal of support and information into these rare diseases to many sufferers around the world.  <br>
        </p>
        <table width="90%" border="1" align="center" cellpadding="7" cellspacing="0">
          <tbody>
            <tr>
              <td><em><strong>Mental Health: </strong></em><br>
                <a href="http://www.meboblog.com/search/label/Mental%20Health%20Monthly%20Column" target="_blank"><strong>VIEW OUR MONTHLY MENTAL HEALTH COLUMN (Blog)</strong></a> in association with the MEBO Mental Health Program.<br>
The program is directed by Crissan Rosalia, Health Psychologist, MSc., MEBO Mental Health Director.</td>
            </tr>
          </tbody>
        </table>
        <br>
          <br>
          <a href="http://meboblog.com" target="_blank" style="color:black; font-weight:bold; display:inline-block; height:40px; background-color:#214553; color:#fff; font-size: 120%; padding:7px ">MEBO BLOG: Visit our long-standing blog for an extensive archive of knowledge.</a><br>
        </p>
        <hr>
        <p><strong>A BRIEF SUMMARY OF METABOLIC BODY ODOR:</strong><br>
          <br>
        Metabolic body malodor occurs when one or more of our internal cell enzyme(s), such as the <a href="https://www.ncbi.nlm.nih.gov/books/NBK1103/" target="_blank">Flaving containing mono-oxygenase3</a> (FMO3) metabolic enzyme, is deficient, rendering the the body unable to deodorize an odorous chemical. Consequently, a significant amount of the odorous unmetabolized volatile organic compound (VOC) builds up in the body and exits through the skin, nose, mouth, and other orifices.</p>
        <p><strong><a href="TRIMETHYLAMINURIA.html">Genetic trimethylaminuria</a> </strong>is one such example of these rare metabolic malodor disorders. Difficult-to-control body and/or breath malodor can be triggered by hormonal changes, stress, and/or diet and intestinal function or structure. In many cases, physicians are likely to resort to an Olfactory Reference Syndrome diagnosis, a psychological diagnosis, and thus, the true underlying body odor diagnosis is not represented. As noted in a research paper, <a title="" href="https://www.ncbi.nlm.nih.gov/pubmed/21851918" target="blank">Individuals Reporting Idiopathic Malodor Production: Demographics and Incidence of Trimethylaminuria.</a> [Wise PM, Eades J, Tjoa S, Fennessey PV, Preti G.], &ldquo;We speculate that testing also might reveal cases of trimethylaminuria among those diagnosed with certain psychologic disorders, including olfactory reference syndrome.&rdquo;<br>
          <br>
        MEBO also recognizes that there are many unknown body odors which have yet to be classified and investigated, some falling under the term &quot;Fecal Body Odor,&quot; or &quot;FBO.&quot; Included in the scope of MEBO's work, is investigation into a condition most commonly called &quot;PATM&quot; (&quot;People Allergic To Me&quot;). More information on this condition and the studies which support proof of it's ongoing investigation among researchers can be found in the MEBO Blog - <a href="http://www.meboblog.com/search?q=PATM" target="_blank">please click here for more information on PATM</a>.<br>
        We hope to investigate the symptoms, causes, and gather sufferer feedback in reported cases and find ways to investigate this prominent population of the odor / PATM sufferer community.
        </p>
        <p><strong><a href="http://meboblog.com" target="_blank" style="color:black; font-weight:bold">MEBO BLOG: </a><a href="https://meboblog.com" style="color:black" >
		Visit our long-standing blog for an extensive archive of knowledge.</a></strong>
		<a href="https://meboblog.com" style="color:black" ></a></p>
        <p><a href="TRIMETHYLAMINURIA.html">VIEW MORE<strong> IN-DEPTH INFORMATION ABOUT TRIMETHYLAMINURIA</strong></a>.<br>
          <br>
          <a href="https://www.meboblog.com/search/label/PATM studies" target="_blank">VIEW MORE<strong> IN-DEPTH INFORMATION ABOUT PATM</strong></a>.<br>
        </p>
        <hr>
        <p><strong><img src="./images/mebo-wplogo3.jpg" alt="mebo logo" width="136" height="53"><br>
          <br>
        MEBO&rsquo;s main strategies are :</strong></p>
        <p>1: Encourage Self Help<br>
          2: Engage Professional Help<br>
          3: International TMAU Test Program*<br>
          4: Raising Awareness in the Public and Medical Community<br>
		  
		  <div id="testing" class="container-fluid row">
          <strong>TESTING:</strong><br>
        <em><strong>* The latest MEBO TMAU Urine Test program ran from July, 2016 until June, 2017.</strong></em> This program is currently re-structuring.<br>
        <a href="https://www.meboblog.com" target="_blank">Please subscribe to our Blog if you wish to be notified when it is restarted</a>. <br>
        MEBO's goal in creating a TMAU Urine test program, is to provide low-cost testing for all sufferers.
        </p>
       <!-- <p><strong>TO GET TESTED PLEASE BEGIN WITH OUR ONLINE REQUISTION FORM:</strong><br>
        <a href="https://meboresearch.limeask.com/48699/lang-en" target="_blank">https://meboresearch.limeask.com/48699/lang-en        </a></p> -->
        <hr>
        <br>
		</div>
		
       <p><strong>PROFESSIONAL NETWORK:</strong><br>
          MEBO Research is proud to be an Organization Member of <a title="MEBO IS A NORD Organization Member" href="http://www.meboblog.com/2012/03/mebo-research-is-national-member.html" target="blank">NORD,</a> the National Organization of Rare Disorders (US), and an Organisation Member of <a title="MEBO is a EURORDIS Organisation Member" href="http://www.meboblog.com/search/label/Eurordis%20Membership" target="blank">EURORDIS,</a> the European Organisation for Rare Diseases. Two MEBO Directors are Moderators of the Trimethylaminuria Community pages of EURORDIS and NORD&rsquo;s partnership website, <a href="https://www.rareconnect.org/en/community/trimethylaminuria" target="blank">RareConnect.org</a>. In addition, MEBO Research is listed as a patient organisation with <a href="http://www.orpha.net/consor/cgi-bin/SupportGroup_Search.php?lng=EN&data_id=94333&title=MEBO-Research--England-and-Wales-" target="blank">Orphanet,</a> and listed with <a href="https://diseaseinfosearch.org/organization/MEBO+RESEARCH/1255" target="blank">Genetic Alliance</a></p>
        <hr>


            <h2>Conditions</h2>
            <ul>
<li><a href="TRIMETHYLAMINURIA.html">Trimethylaminuria</a>
            </ul>
			<h2>Support Groups</h2>
            <ul>
			<li><a href="https://www.facebook.com/groups/MEBO.SUPPORT">MEBO Support FB group</a> - 1.2K members
			<li><a href="https://www.facebook.com/groups/715913928557803">MEBO PATM FB group</a> - 2.3K members
			<li><a href=" https://www.medhelp.org/posts/People-Allergic-to-Me-PATM/People-Are-Allergic-To-Me-PATM/show/4415">
			     MedHelp PATM group</a> - 1K members

            <li><a href="https://www.rareconnect.org/en/community/trimethylaminuria">Trimethylaminuria community at RareConnect</a> - 3.6K members
            </ul>
        </div>
        <div class="col-sm-2"></div>
    </div>
</div>

<div id="program" class="container-fluid bg-grey">
    <div class="row">
        <div class="col-lg-2"></div>
        <div class="col-lg-8">
            <h2 style="margin-bottom: 0;">Events</h2>
                        <p></p>
				
				
				
				                       <small>MEBO Webinars & Interviews</small>
                        <br>
           <div class="session-break">
                    <div class="session-title">
                        <i class="fas fa-lightbulb" style="font-size: 4rem; color: #ffbb73;"></i>
 </div>
                </div>		


				<div class="session-break">
                    <div class="session-title">
					
					<li><a href="https://www.meboblog.com/2020/09/prof-elizabeth-shephard-tmau-interview.html
					">
					Dr. Shephard, 2020: interview
					</a>
					
					
					
					
					<li><a href="https://www.meboblog.com/2017/04/rareconnect-tmau-webinar-dr-yiran-guo.html
					">
					Dr. Guo, 2017: Genetic Analysis of TMAU
					</a>
					
					
					
					<li>
                        <a href="https://www.meboblog.com/2012/11/webinar-transcription-of-dr-lachmanns.html">
						
						Dr. Lachmann, 2012: Treatment and followup monitoring for TMAU</a>
						
						
					<li><a href="https://www.meboblog.com/2012/12/tmau-webinar-with-dr-mackay-great.html
					">
					Dr. Mackay, 2012: TMAU metabolism
					</a>
					
					
					<li><a href="https://www.meboblog.com/2012/09/tmaufmo3-webinar-recording-professors.html
					">
					Drs. Shephard and Phillip, 2012: FMO3
					</a>
					
					<li><a href="https://www.meboblog.com/2010/02/test-webinar-microbes-and-us-slide.html
										">
					Dr. Gabashvili, 2010: Microbes & us
					</a>

 
 </div>
                </div>
				               <p></p>
				
	
		<br>		
 					                        <small>MEBO Annual Conferences</small> 

                <div class="containertime timeleft" style="margin-top: 0;">
                    <div class="timecontent">
                         <p></p>
                    </div>
                </div>
                <div class="containertime timeright">
                    
                </div>
                
                <div class="session-break">
                    <div class="session-title">

                        <i class="fas fa-wine-glass-alt fa-lg" style="font-size: 4rem; color: #EE82EE;"></i>
                    </div>
                </div>
                <div class="session-break">
                    <div class="session-title">
					<li>
					<a href="
					https://www.meboblog.com/2018/03/accommodations-agenda-mebo-conference.html">
						 Savannah, GA: 2018</a>;
						 
						 <li>
                         <a href="https://www.meboblog.com/2017/01/mebo-2017-annual-meetup-and-conference.html">
						 Miami Beach, FL: 2017</a>;
						 
						 <li>
						 <a href="
						 https://www.meboblog.com/search/label/Meetup%3A%20Orlando%202015">
						 Orlando, FL: 2015</a>;
						 <li>
						 <a href="
						 https://www.meboblog.com/2013/05/agenda-for-4th-annual-mebo-conference.html
						 ">				 
						 Memphis, TN: 2013</a>;
						 <li>
						 <a href="
						 https://www.meboblog.com/2011/04/highlights-of-mebos-2nd-annual-meetup.html
						 ">				 
						 Washington, DC: 2011</a>;
						 
						 		 <li>
						 					 <a href="
						 https://www.meboblog.com/2010/01/join-us-in-nashville-body-odor-and.html
						 ">
						 Nashville, TN: 2010</a>;
						 
						 
						 <li>
						 <a href="
						 https://www.meboblog.com/2009/12/london-annual-body-odor-halitosis.html">
						 						 London, UK: 2009</a>
						 
                    </div>
                </div>
                <div class="containertime timeleft" style="margin-top: 0;">
  
                </div>  


<br>
			
                <div class="session-break">
                    <div class="session-title">
					
							                       <small>MEBO Virtual Mixers</small>

				<br>
           <div class="session-break">
                    <div class="session-title">
					<i class="fas fa-video" style="font-size: 4rem; color: #74a4b8;"></i>
						                       
                    </div>
                </div>
				<div class="session-break">
                    <div class="session-title">
                        <a href="">
						Zoom, Skype, Facebook</a>
 
 </div>
                </div>	


 <!--
                <div class="session-break">
                    <div class="session-title" style="font-size: 4rem;">
                        <i class="fas fa-camera-retro" style="color: #4d4d4d;"></i>
                        <h5 style="display: inline-block;">&emsp;</h5>
                        <i class="fas fa-coffee" style="color: #b88e67;"></i>
                    </div>
                </div>
   -->




            </div>
        </div>
    </div>
</div>

<div id="contact" class="container-fluid">
    <div class="row">
        <div class="col-sm-2"></div>
        <div class="col-sm-8">
            <h2>Contact</h2>
            <p>For further inquiries, please drop an <a href="mailto:help@meboresearch.org">email</a> or 
			<a href="https://twitter.com/MeBOResearch"><i class="fab fa-twitter"></a></i>. 
			We welcome all suggestions and comments. You can also 
			
			<table>

    <tr>
      <td width="53%"><aside id="text-8" class="widget widget_text"><h3 class="widget-title"><span>Subscribe to Our Blog</span></h3><div class="textwidget"><div style="font-size:85%"><form action="https://www.feedburner.com/fb/a/emailverify" style="border: 1px solid #ccc; padding: 1px; text-align: center" target="popupwindow" method="post" onsubmit="window.open('https://www.feedburner.com/fb/a/emailverifySubmit?feedId=2255956', 'popupwindow', 'scrollbars=yes,width=550,height=520');return true"> <br><strong style=>Enter your email address:</strong><br> <br><input style="width: 95%" name="email" type="text" /></p><input value="https://feeds.feedburner.com/~e?ffid=2255956" name="url" type="hidden" /><input value="Bloodborne Body Odor and Halitosis" name="title" type="hidden" /><input value="en_US" name="loc" type="hidden" /><input value="Subscribe" type="submit" /> <br><span style="font-size:12px">Delivered by <a href="https://www.feedburner.com" target="_blank" style="font-size:12px">FeedBurner</a></form><br><span style="font-size:12px; line-height:auto">You will be sent a verification email. Please click on the verification link in the email. If you do not receive an email, please check your spam folder.</span><br> <a href="https://feeds.feedburner.com/BloodborneBodyOdorAndHalitosis" rel="alternate" type="application/rss+xml"><img alt="" style="vertical-align: middle; border: 0" src="https://www.feedburner.com/fb/images/pub/feed-icon16x16.png" /></a>
	  &nbsp;<a href="https://feeds.feedburner.com/BloodborneBodyOdorAndHalitosis" rel="alternate" type="application/rss+xml">Subscribe in a reader</a><a href="https://feeds.feedburner.com/BloodborneBodyOdorAndHalitosis"><img width="88" style="border: 0; float: right" alt="" src="https://feeds.feedburner.com/~fc/BloodborneBodyOdorAndHalitosis?bg=3300FF&amp;fg=FFFF99&amp;anim=0" height="26" /></a></p></div></div> </aside></td>
      <td width="47%">&nbsp;</td>
    </tr>
    <tr>
      <td colspan="2">&nbsp;</td>
    </tr>
    <tr>
      <td colspan="2"><br>
        <a class="twitter-timeline" data-width="400" data-height="700" href="https://twitter.com/MeBOResearch">Tweets by MeBOResearch</a> <script async src="//platform.twitter.com/widgets.js" charset="utf-8"></script></td>
    </tr>
    <tr>
      <td colspan="2">&nbsp;</td>
    </tr>
	</table>
			
			</p>
        </div>
        <div class="col-sm-2"></div>
    </div>
</div>


<footer class="container-fluid text-center bg-grey">
    MEBO Research, Inc
</footer>


<script src="js/jquery.min.js"></script>
<script src="js/bootstrap.min.js"></script>
<script>
    $(document).ready(function () {
        // Add smooth scrolling to all links in navbar + footer link
        $(".navbar a, footer a[href='#mainPage']").on('click', function (event) {

            // Prevent default anchor click behavior
            event.preventDefault()

            // Store hash
            var hash = this.hash

            // Using jQuery's animate() method to add smooth page scroll
            // The optional number (900) specifies the number of milliseconds it takes to scroll to the specified area
            $('html, body').animate({
                scrollTop: $(hash).offset().top
            }, 900, function () {

                // Add hash (#) to URL when done scrolling (default click behavior)
                window.location.hash = hash
            })
        })

        $(window).scroll(function () {
            $(".slideanim").each(function () {
                var pos = $(this).offset().top

                var winTop = $(window).scrollTop()
                if (pos < winTop + 600) {
                    $(this).addClass("slide")
                }
            })
        })
    })
</script>

</body>
</html>


<!-- Add Google Maps -->
<!--<script src="http://maps.googleapis.com/maps/api/js"></script>-->
<!--<script>-->
<!--/*var myCenter = new google.maps.LatLng(37.385270,-5.991906);-->

<!--function initialize() {-->
<!--var mapProp = {-->
<!--center:myCenter,-->
<!--zoom:17,-->
<!--scrollwheel:false,-->
<!--draggable:false,-->
<!--mapTypeId:google.maps.MapTypeId.ROADMAP-->
<!--};-->

<!--var map = new google.maps.Map(document.getElementById("googleMap"),mapProp);-->

<!--var marker = new google.maps.Marker({-->
<!--position:myCenter,-->
<!--});-->

<!--marker.setMap(map);-->
<!--}-->

<!--google.maps.event.addDomListener(window, 'load', initialize);*/-->
<!--</script>-->